Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Heerma currently holds 140,684 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Heerma has been a net seller of TVTX stock. They have purchased $0 and sold $1.7M worth of shares.
Peter Heerma's most recent insider trade was on May 5, 2026, when they sold 2,174 shares at $46.65 per share.
Peter Heerma serves as Executive at Travere Therapeutics, Inc. (TVTX). They have executed 41 insider transactions totaling $1.7M over their tenure at the company.
Peter Heerma holds the position of Executive at Travere Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Peter Heerma has shown a selling trading pattern, with $0 in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter Heerma was on Apr 14, 2026, when they sold $302.5K worth of TVTX shares. This transaction involved 7,215 shares at $41.93 per share.
Peter Heerma currently owns 140,684 shares of Travere Therapeutics, Inc. (TVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Heerma's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Heerma has 41 Form 4 filings on record as an insider at Travere Therapeutics, Inc..
Set alerts for Peter Heerma and 40,000+ other insiders.